Sensei Biotherapeutics to Present Initial Clinical Data
BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery...
Source: globenewswire.com
Stay updated with breaking news from F Donelson Smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery...